Quantitative assessment of placental morphology may identify specific causes of stillbirth by Imogen Ptacek et al.
RESEARCH ARTICLE Open Access
Quantitative assessment of placental
morphology may identify specific causes of
stillbirth
Imogen Ptacek1,2, Anna Smith3, Ainslie Garrod1,2, Sian Bullough1,2, Nicola Bradley1,2, Gauri Batra3, Colin P. Sibley1,2,
Rebecca L. Jones1,2, Paul Brownbill1,2 and Alexander E. P. Heazell1,2*
Abstract
Background: Stillbirth is frequently the result of pathological processes involving the placenta. Understanding the
significance of specific lesions is hindered by qualitative subjective evaluation. We hypothesised that quantitative
assessment of placental morphology would identify alterations between different causes of stillbirth and that
placental phenotype would be independent of post-mortem effects and differ between live births and stillbirths
with the same condition.
Methods: Placental tissue was obtained from stillbirths with an established cause of death, those of unknown
cause and live births. Image analysis was used to quantify different facets of placental structure including: syncytial
nuclear aggregates (SNAs), proliferative cells, blood vessels, leukocytes and trophoblast area. These analyses were
then applied to placental tissue from live births and stillbirths associated with fetal growth restriction (FGR), and to
placental lobules before and after perfusion of the maternal side of the placental circulation to model post-mortem
effects.
Results: Different causes of stillbirth, particularly FGR, cord accident and hypertension had altered placental
morphology compared to healthy live births. FGR stillbirths had increased SNAs and trophoblast area and reduced
proliferation and villous vascularity; 2 out of 10 stillbirths of unknown cause had similar placental morphology to
FGR. Stillbirths with FGR had reduced vascularity, proliferation and trophoblast area compared to FGR live births. Ex
vivo perfusion did not reproduce the morphological findings of stillbirth.
Conclusion: These preliminary data suggest that addition of quantitative assessment of placental morphology may
distinguish between different causes of stillbirth; these changes do not appear to be due to post-mortem effects.
Applying quantitative assessment in addition to qualitative assessment might reduce the proportion of unexplained
stillbirths.
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Background
Histological examination of the placenta is one of the
most frequently performed investigations to identify the
cause of death in cases of stillbirth [1]; its application in
this context is recommended by international guidelines
[2–4]. A recent systematic review found large variations
in the methodological quality of studies of placental
examination after stillbirth, with few studies of high
quality [5]. Interpretation of the results of such studies is
further complicated by the use of different classification
systems and a lack of consensus in terminology used to
describe placental lesions which results in a large vari-
ation in the proportion of stillbirths attributed to a pla-
cental “cause” from 11–65 % [5]. Such qualitative
placental assessment, combined with varied terminology,
has some deficiencies. Firstly, qualitative assessment of
placental lesions may introduce bias, particularly if as-
sessors are not blinded to outcome. Furthermore, quali-
tative assessment may lead to inter-observer variation in
diagnoses, which ranged from 25–91 % in one study [6].
The significance of specific abnormalities to stillbirth
has also been questioned by Pathak et al. who describe
placental abnormalities in a significant proportion of ap-
parently healthy live-born infants [7]. Finally, identifica-
tion of a specific lesion does not imply a single cause.
For example, appearances of fetal thrombotic vasculopa-
thy have been associated with various pathologies in-
cluding: cytomegalovirus infection [8], umbilical cord
accidents [9] or specific patterns of umbilical cord coil-
ing [10]. Similarly, changes of maternal underperfusion
may be related to hypertensive disorders [11] and anti-
phospholipid syndrome [12].
Recently, significant advances have been made in
the development of modern classification systems
[13–15] that reduce the proportion of unexplained
stillbirths [16]. These classification systems have given
greater recognition to the role of placental pathology
in the aetiology of stillbirth [13–15] and progress has
been made in reducing the variation of placental
histological findings [6]. However, these clinically-
orientated descriptions of placental phenotype have
not yet been adopted into widespread practice, in part
due to continued debate about terminology which
varies between clinical and research studies [17]. Re-
search studies have employed quantitative descriptions
of placental morphology by stereology and morphom-
etry to describe differences in placental structure in
clinical conditions related to stillbirth such as fetal
growth restriction (FGR) [18] and reduced fetal move-
ments [19]. We aimed to use these quantitative
methods to objectively evaluate placental appearances
of different causes of stillbirth. Firstly, we hypothe-
sised that specific causes of stillbirth would be associ-
ated with a morphometric phenotype. Secondly, we
hypothesised that morphological abnormalities associ-
ated with stillbirth would differ from live births with
the same condition. To be of diagnostic value, any
observed changes should not represent artefacts of
storage or cessation of fetal blood flow after death.
Since we have already described the effects of placen-
tal storage on placental structure [20], here we ad-
dress a third hypothesis that there is an acute effect




To address the first hypothesis we obtained placental
tissue from cases of stillbirth, defined as the birth of
an infant with no signs of life after 24 weeks gesta-
tion. Parents gave permission for the use of samples
for research at the time of consent for post-mortem
examination. A favourable ethical opinion was given
by the Greater Manchester South Research Ethics
Committee (09/H1012/11) and approval given from
the Research and Innovation Division of Central
Manchester University Hospitals NHS Foundation
Trust to conduct the study. Cases of stillbirth were
classified using the ReCoDe system [15] by a
multidisciplinary meeting following a full panel of in-
vestigations including: post-mortem, histopathological
examination of the placenta, chromosomal analysis
and maternal biochemical, haematological, immuno-
logical and serological tests. We obtained samples
from the following classifications of stillbirth: cord ac-
cident (n = 8), diabetes (n = 5), FGR (n = 10), hyperten-
sion (n = 8), infection (n = 8) and from stillbirths of an
unknown cause (n = 10). For comparison, matched
placental samples were used from appropriately-grown
live born infants and preterm births (26-36 weeks)
(demographics shown in Table 1). Samples from live
births were collected following written informed con-
sent as part of the Maternal and Fetal Research
Centre (MFHRC) Biobank (08/H1010/55). To address
the second hypothesis, placental samples were taken
from a further cohort of stillbirths attributed to FGR
(n = 13) and from live births with FGR (n = 13) with
the same ethical approvals as described above. FGR
was defined as a customised birthweight <5th centile
(demographics shown in Table 2). To address the
final hypothesis, placental tissue was obtained from
appropriately grown (n = 7) and FGR (n = 5) live
births following written informed consent as part of
the MFHRC biobank previously described. For all
cases, maternal and infant demographic information
was recorded from medical case notes and post-
mortem reports (for stillbirths). An estimate of the
duration of in utero retention was made according to
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Table 1 Demographic characteristics of samples from live births and stillbirths from known and unknown causes. Birthweight was significantly lower in stillbirths from FGR and
hypertension than live births (P < 0.01); all other variables did not significantly differ between groups. Data are presented as median with range in parentheses except for
estimated time of retention in utero where number of cases are presented
Live births Preterm birth Cord Diabetes Hypertension Infection FGR Unknown
Number of Samples 10 7 8 5 8 9 10 10
Maternal Age (years) 32 (28–37) 27 (18–41) 28 (21–36) 34 (31–40) 33 (27–37) 30 (25–32) 30 (22–32) 28 (21–31)
Gravidity 1 (1–5) 3 (1–6) 1 (1–1) 4 (2–7) 1 (1–2) 1 (1–3) 1 (1–4) 1 (1–2)
Parity 0 (0–4) 0 (0–4) 0 (0–0) 1 (1–2) 0 (0–0) 0 (0–2) 0 (0–2) 0 (0–0)
Gestation at delivery
(weeks)
37 (37–38) 31 (26–36) 30 (27–38) 28 (28–40) 31 (26–35) 38 (24–41) 34 (26–38) 31 (27–39)
Birthweight (g) 3090 (2805–3430) 1821 (786–2760) 1300 (702–2750) 3120 (1473–3590) 1110 (399–1730) 2680 (494–2985) 1065 (564–2230) 2170 (892–3150)
Estimated in utero
retention time
0 h - <24 h N/A N/A 0 1 4 4 2 2
≥24 h - < 48 h 1 0 2 2 4 3
≥48 h - < 96 h 2 1 0 2 2 1
≥96 h - <1 week 3 1 1 0 0 2











Genests’ descriptions of findings at post-mortem and
from histopathological examination of the placenta
[21–23].
Tissue from live births was obtained within 30 min of
delivery. For assessment of placental morphology biop-
sies of villous tissue were dissected from the centre,
middle and edge of the placenta. Tissue was fixed in 4 %
neutral buffered formalin for 24 h before being wax em-
bedded. For stillbirth samples three blocks of placental
tissue not obtained from specific lesions were obtained
for each placenta.
Placental perfusion
Unless otherwise stated, all reagents were supplied by
Sigma-Aldrich Chemical Company (Poole, UK). To
examine the acute impact of continued maternal
blood flow in the absence of fetal blood flow single-
sided (maternal) ex vivo human placental lobule per-
fusion was adapted from the dual-sided perfusion
model [24]. Perfusion was performed on placentas
from normal pregnancy (n = 7) and placentas from
pregnancies complicated by FGR (n = 5). An intact
peripheral lobule was selected, devoid of post-partum
tears, deep decidual damage and marginal membrane
separations. Prior to perfusion two villous biopsies
were sampled from neighbouring lobules taken 5 cm
apart, and fixed immediately in 4 % neutral buffered
formalin forming “pre-perfusion samples”. The fetal
artery and vein on the chorionic surface, serving the
villous trees within the lobule designated for perfu-
sion, were each ligated using sutures (Mersilk 3/0,
Ethicon, supplied by NuCare, UK) to confine a static
fetal blood pool within the fetal vasculature of the as-
sociated cotyledons. The maternal surface was cannu-
lated using five 10 cm lengths of polythene tubing
(Smiths Medical, UK) arising from a perfusion mani-
fold (Harvard Apparatus, UK). The distal ends of the
cannulae were cut into apices and inserted through
the decidual surface of the lobule with an even spatial
distribution. The perfusate was modified Earle's bicar-
bonate buffer (EBB 117 mM NaCl, 10.7 mM KCl,
5.6 mM D-glucose, 3.6 mM CaCl, 1.8 mM NaH2PO4,
13.6 mM NaHCO3, 0.04 mM L-arginine, 0.8 mM
MgSO4, 3.5 % (w/v) dextran, 0.1 % (w/v) bovine
serum albumin, 5000 IU/L Heparin sodium) equili-
brated with 95 % O2 / 5 % CO2 to pH 7.4 and
warmed to 37 °C, delivered by a roller pump (Watson
Marlow, UK) at 14 ml/min. Lobule preparations were
only considered acceptable for experimentation when
maternal-side perfusion was established within 30 min
of delivery. Open-circuit perfusion was for 6 h, and
then the physiological buffer was switched to a 4 %
neutral buffered formalin at T = 6 h for a 10 min
maternal-side perfusion fixation period. Following
this, the lobule was excised and two further full
thickness (vertical and horizontal) biopsies slices were
taken as the “post-perfusion samples”. These wide tis-
sue sections where then immersion fixed in 4 % neu-
tral buffered formalin for 24 h before being wax
embedded. Placental structure in these biopsies was
examined as described above.
Immunohistochemistry
Placental cell turnover, structure and vascularity were
assessed using antibodies specific for Ki67 (Dako, Ely,
Cambridgeshire, UK; 0.16 μg/ml), cytokeratin 7 (Dako;
0.9 μg/ml) and CD31 (Dako; 0.16 μg/ml). The num-
ber of leukocytes was assessed by an antibody specific
for CD45 (Dako; 0.4 μg/ml). Negative controls were
performed using non-immune mouse IgG (Dako) at
matching concentrations to the primary antibody.
Immunohistochemistry was performed as previously
described with antigen retrieval performed by micro-
waving the sections for 10 min in 0.01 M sodium cit-
rate buffer [19, 20].
Quantification of syncytial nuclear aggregates (SNAs,
also known as syncytial knots) was conducted on
sections stained with haematoxylin and eosin as
Table 2 Demographic details of samples used for experimental comparisons. The left hand columns relate to samples obtained
from cases of FGR that were live or stillborn; all these samples had a birthweight <5th centile. The right hand columns relate to
samples used for perfusion experiments. Data are presented as median with range in parentheses
FGR live birth FGR still birth Appropriate for gestational age - placental perfusion FGR - placental perfusion
Number of Samples 13 13 7 5
Maternal Age (years) 32 (20–40) 23 (19–42) 33 (27–36 31 (23–39))
Gravidity 2 (1–9) 2 (1–3) 2 (2–4) 1 (1–5)
Parity 1 (0–8) 0 (0–2) 2 (1–2) 1 (0–5)
Gestation at delivery (weeks) 37 (30–41) 35 (28–38) 39 (39–39) 38 (35–39)
Birthweight (g) 1389 (536–3060) 1010 (385–2000) 3740 (2910–3940) 2262 (1900–2440)
Mode of delivery (% Caesarean) 69 0 71 89
Infant gender (% Female) 54 62 57 78
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previously described [19, 20]. Dewaxed and rehydrated
sections were stained with Harris’s haematoxylin for
10 min before differentiation in acid-alcohol. Slides were
stained with eosin for 2 min, rinsed in cold tap water,
and dehydrated and mounted as described above.
For all analyses images were captured using an
Olympus BX41 light microscope (Southend-on-Sea,
UK) and QIcam Fast 1394 (QImaging, BC, Canada)
and Image Pro Plus 6.0 and 7.0 (Media Cybernetics
Inc., MD, USA). During image acquisition and ana-
lysis the presumed cause of stillbirth was concealed
from the observer. Between images the microscope
was taken out of focus to prevent selection bias, if
the randomly selected image was not mostly of ter-
minal villi another area was identified. Five random
images of terminal villi were taken of each section,
giving a total of 15 images per placenta for each
component evaluated.
Assessment of placental structure
The number of SNAs were counted and total villous
area measured using image analysis software, expressed
Fig. 1 a Assessment of syncytial nuclear aggregates (SNAs) in different causes of stillbirth compared to healthy live births. SNAs are shown by
open arrows in representative images from normal pregnancy and stillbirth associated with hypertension. b Assessment of proliferation in
different causes of stillbirth compared to healthy live births. c Assessment of trophoblast area in different causes of stillbirth compared to healthy
live births. Negative control images shown in small panel beneath representative images of normal pregnancy and FGR. Scale bar = 50 μm in all
images. Graphs show median and range, * p < 0.05, ** p < 0.01, *** p < 0.001. Dotted line indicates median level of healthy control
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as the number of SNAs per mm2 of villous tissue as pre-
viously described [25]. Proliferative index was the num-
ber of Ki67 positive nuclei as a proportion of total nuclei
as previously described [19, 20]. Vascularity was
expressed as the number of capillaries per terminal villus
and the percentage of avascular villi (defined as a villus
with no evidence of CD-31 immunostaining or morpho-
logical evidence of vessels) [19, 20]. Trophoblast area
was expressed as the proportion of villous area positive
for CK-7 immunostaining. The number of leukocytes
was assessed by the number of CD45 positive cells per
1,000 nuclei.
Statistical analysis
For comparison of different causes of stillbirth data from
each variable was compared to the median level in
healthy controls using Wilcoxon signed rank test. Cases
of FGR that were live-born were compared to those who
were stillborn using Mann-Whitney U test. Data from
pre- and post-perfusion samples were compared using
Wilcoxon matched-pairs test. Demographic variables
were compared using Kruskal-Wallis test with Dunn’s
post-hoc test for multiple comparisons and Mann-
Whitney U test for single comparisons. For all statistical
tests a p-value of 0.05 was considered to be statistically
Fig. 2 a Assessment of villous vascularity in different causes of stillbirth compared to healthy live births. b Proportion of avascular villi in different
causes of stillbirth compared to healthy live births. Avascular villi are highlighted in red. c Assessment of the number of leukocytes in different
causes of stillbirth compared to healthy live births. Negative control images shown in small panel beneath representative images of normal
pregnancy and FGR. Scale bar = 50 μm in all images. Graphs show median and range, * p < 0.05, ** p < 0.01, *** p < 0.001. Dotted line indicates
median level of healthy control
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Table 3 Pattern of placental morphology in placental samples from stillbirths of unknown cause (n = 10) demonstrating two
samples with a very similar pattern to samples from FGR (highlighted in grey)
Sample SNAs Proliferation Vascularity Avascular villi Trophoblast Leukocytes Profile
Unknown 1 Low High Unchanged High Low Low Not similar
Unknown 2 High Unchanged Low High Unchanged Unchanged Not similar
Unknown 3 High Low Low High High Unchanged Similar to FGR
Unknown 4 High Unchanged High Unchanged Unchanged Unchanged Not similar
Unknown 5 High Low Low High High Unchanged Similar to FGR
Unknown 6 High Unchanged Low High Unchanged Unchanged Not similar
Unknown 7 Unchanged Unchanged Low High Unchanged Unchanged Not similar
Unknown 8 Unchanged High Low High Increased Low Not similar
Unknown 9 High Unchanged Low High Increased High Not similar
Unknown 10 Unchanged Unchanged Low High Increased Unchanged Not similar
Fig. 3 Assessment of placental morphometry in live births associated with FGR compared to stillbirths associated with FGR. Graphs present data
for a) Syncytial nuclear aggregates (SNAs) b) Proliferation, c) Trophoblast area, d) Villous vascularity, e) Proportion of avascular villi and f) Number
of Leukocytes. Graphs show median and range, * p < 0.05, ** p < 0.01, *** p < 0.001
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significant. All statistical analyses were carried out using
GraphPad PRISM (Version 6, La Jolla, CA).
Results
Placental morphology in different causes of stillbirth
In comparison to normal pregnancy, SNAs were in-
creased in stillbirths attributed to cord accident, hyper-
tension, FGR and in stillbirths with an unknown
aetiology (Fig. 1a). This was in contrast to fewer SNAs
seen in preterm live births. Proliferation was reduced in
all cases of stillbirth, but was particularly reduced in
those cases attributed to cord accident or FGR (Fig. 1b).
The median trophoblast area (measured as cytokeratin-7
positive area) was increased in stillbirths attributed to in-
fection and FGR (Fig. 1c). The median number of blood
vessels identified by CD31 immunostaining was signifi-
cantly reduced in stillbirths attributed to FGR and those
with an unknown cause (Fig. 2a). The number of
Fig. 4 Assessment of placental morphometry before and after maternal-side only placental perfusion in normal and FGR placentas. Graphs
present data for a reduction in a) syncytial nuclear aggregates (SNAs), but no change in b) Proliferation, c) Trophoblast area, d) Villous vascularity,
e) Proportion of avascular villi and f) Number of Leukocytes. Graphs show median and range, * p < 0.05. Representative images of each feature
are shown. Scale bar = 50 μm in all images
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avascular villi was significantly increased in these condi-
tions, although an increase in avascular villi was also
seen in stillbirths attributed to cord compression and
hypertension (Fig. 2b). These changes were in contrast
to an increase in vascularity and reduction in avascular
villi observed in preterm live births. The median number
of leukocytes was reduced in stillbirths attributed to ma-
ternal hypertension and FGR compared to healthy con-
trols (Fig. 2c). It is important to note that in some
variables, notably the number of leukocytes in cases of
infection, there was a wide range in measurements ob-
tained. The cause of stillbirth with the most placental
differences from healthy pregnancies was FGR, which
has increased numbers of SNAs, reduced proliferation,
increased trophoblast area, fewer blood vessels per vil-
lus, more avascular villi and decreased numbers of leu-
kocytes. Interestingly, the condition with next most
frequent abnormalities was stillbirths of unknown cause.
When the individual profiles of stillbirths from unknown
cause are examined, two had a similar profile to those
with FGR and others had similar features such as in-
creased density of SNAs and reduced vascularity
(Table 3). None of the features examined altered accord-
ing to the estimated duration of in utero retention (Add-
itional file 1: Figure S1).
When compared to FGR live births, FGR stillbirths did
not have increased numbers of SNAs but had reduced
proliferation and trophoblast area, fewer blood vessels
per villus and a greater proportion of avascular villi.
Leukocytes were increased in FGR stillbirths compared
to FGR live births (Fig. 3).
Effect of short-term fetoplacental haemostasis on
placental morphology
To assess changes that may happen in utero after cessa-
tion of fetal blood flow, placental tissue was examined
before and after maternal-side only placental perfusion
in placental tissue from healthy and FGR pregnancies.
Perfusion in this manner for 6 h was not associated with
any changes in proliferation, trophoblast area, villous
vascularity or the proportion of avascular villi (Fig. 4).
Maternal-side only perfusion was associated with a re-
duction in the number of SNAs in normal tissue (Fig. 4a).
There was a consistent trend towards lower numbers of
leukocytes in perfused tissue from both appropriately-
grown and FGR pregnancies (p = 0.08).
Discussion
This pilot study demonstrates that objective assess-
ment of placental morphology may provide additional
information on placental villous structure in cases of
stillbirth and in some cases, such as in FGR, can dif-
ferentiate between specific causes of stillbirth and
healthy live-born infants. In other cases, such as
stillbirths attributed to maternal diabetes, there were
no morphological differences from live-born infants,
which is consistent with few histopathological abnor-
malities in stillbirths related to diabetes [26]. When
the morphometric profile was applied to ten stillbirths
of unknown cause, two had a very similar placental
profile to FGR, which suggests that some stillbirths
that currently have no identified cause (despite inten-
sive investigation) may actually result from FGR in a
fetus that was not small, i.e. infants who have a birth-
weight >10th centile but whose growth rate was slow-
ing down. These preliminary findings suggest that
addition of objective assessment of placental morph-
ology to histological examination with the use of a
modern classification system may further decrease the
proportion of unexplained stillbirths. However, further
research is needed to understand the role that abnor-
malities of placental structure and function have in
the aetiology of stillbirth both in the presence of a
small fetus and when the birthweight is within an ac-
cepted normal range [27].
The findings in FGR stillbirths are consistent with other
stereological and morphometric assessment of FGR pla-
centas including: increased SNAs [25], reduced villous
vascularity [28], reduced proliferation [29] and number of
cytotrophoblasts [28]. The pattern seen in FGR stillbirths
was also consistent with the placental morphology in
women with reduced fetal movements [19], who are at in-
creased risk of stillbirth [30]. However, some results differ
from other studies, one of which describes a positive rela-
tionship between trophoblast area and birthweight [31].
The reduced trophoblast area in stillbirth FGR compared
to healthy live births contrasts with an increased area rela-
tive to live born FGR infants. This observation may result
from thicker syncytiotrophoblast covering hypoplastic
villi; application of stereological techniques is required to
explore this observation in greater depth.
The findings of this study are consistent with the Still-
birth Collaborative Research Network (SCRN) case-
control study which found increased presence of placen-
tal lesions in stillbirths, including: diffuse terminal vil-
lous immaturity, inflammation, vascular degeneration in
the chorionic plate, intra-placental thrombi, avascular
villi and parenchymal infarction [32]. The SCRN study
found differences in lesions depending on gestation.
Avascular villi and fetal vascular thrombi were more fre-
quently seen in term stillbirths than those occurring at
earlier gestations. Whereas, chorioamnionitis was seen
less frequently in stillbirths than live births at 24 weeks’
gestation, but more frequently in term stillbirths com-
pared to matched live births [32]. The SCRN study pro-
vides evidence that different causes of stillbirth have a
different placental phenotype and addition evidence that
gestation may affect the cause of stillbirth. Our study
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demonstrated that some features (SNAs and villous vas-
cularity) were altered in preterm compared to term live
births. Critically, these changes were in the opposite dir-
ection to that seen in stillbirth, so the morphology
changes seen in cases of stillbirth cannot be attributed
to their preterm gestation.
The finding that the placental phenotype of FGR still-
births had reduced villous vascularity, increased avascu-
lar villi and increased leukocyte infiltration compared to
live-born FGR may imply that FGR stillbirths result from
a more severe placental phenotype. However, these dif-
ferences must be interpreted cautiously, as differences
between live and stillbirth may also result from artefacts
from cessation of fetoplacental blood flow after fetal
death, differences in mode of delivery or from storage
prior to fixation. Our previous experimental data suggest
that storage prior to fixation for ≤48 h does not alter
any of the indices measured here [20]. Studying the ef-
fects of in utero retention is more challenging. We
attempted to model this by maternal-side only placental
perfusion for 6 h, finding that this did not reproduce any
of the differences between FGR stillbirths and live births.
However, the duration of perfusion was limited by the
experimental technique and it cannot reproduce the in
utero environment (e.g. presence of the maternal im-
mune system). Placental changes may be altered by the
duration of in utero retention, as evident by changes in
histopathological appearances of the placenta in fetal
maceration [33]. Thus, further study is needed to deter-
mine the effects of potential confounders, particularly in
utero retention, on the quantitative measures used in
this study. This could be explored by evaluating the
morphology of stillbirths with known in utero retention
time (e.g. intrapartum events, feticide for structural
anomaly). The possibility that morphological changes
might arise from differences in mode of delivery should
also be considered, as Caesarean section is rarely used in
cases of stillbirth, but is frequently employed in live born
FGR infants; this can be resolved by detailed study of
placental morphology after vaginal delivery and Caesar-
ean section.
The study reported here is strengthened by a detailed
assessment of multiple aspects of placental morphology
with blinding of assessor to study group or pregnancy
outcome. We also have compared cases of stillbirth to
appropriately-grown healthy controls and preterm births
primarily recruited for research rather than clinical cases
with indication(s) for perinatal histology. The use of ob-
jective techniques that also have been used to evaluate
related conditions allows comparison between different
clinical situations. However, this study does have limita-
tions: although 50 samples from well-characterised still-
births have been analysed, this only amounts to ≤10
samples per group and these were obtained from a single
Paediatric and Perinatal Pathology department. Unfortu-
nately, at the time of collection the collection protocols
between the clinical histopathological service and re-
search laboratories were slightly different resulting in
different numbers of samples obtained per placenta po-
tentially introducing a bias between samples from still-
births and live births. However, we believe the chance of
selection bias to be low as placental tissue was randomly
sampled and blocks of specific lesions were not used in
either protocol. Samples were divided into groups based
upon the classification of stillbirth determined by multi-
disciplinary review (involving obstetricians, midwives,
sonographers and pathologists) and, although this was
made as robust as possible, it is possible that the cause
of death was different from that attributed in the peri-
natal review process.
Conclusion
Due to the critical role played by the placenta in de-
termining the outcome of pregnancy and the role of
placenta failure in the aetiology of stillbirth [34], pla-
cental histology is a frequently employed investigation
that can provide important information for clinicians
and parents regarding the reasons for their child’s
death [35]. When combined with a modern classifica-
tion system, histological examination of the placenta
reduces the proportion of unexplained stillbirths [36,
37]. Our preliminary findings suggest that addition of
objective measurement of placental structure may add
to understanding of the cause of stillbirth. These
quantitative observations need to be related to estab-
lished qualitative descriptions; in some cases such as
avascular villi and fetal thrombotic vasculopathy this
may be straightforward, in others, such as placental
maturation disorders, this may be more complex.
Prior to clinical application further studies are needed
to develop normal ranges for these morphological
characteristics at different gestational ages and to
determine the effects of in utero retention on these
indices. Then blinded studies of randomly sampled
cases of stillbirth from multiple populations are
needed to ensure the findings presented here are suf-
ficiently sensitive and specific for diagnostic use.
Additional file
Additional file 1: Figure S1. Assessment of placental morphometry in
stillbirths (irrespective of cause) grouped by estimated time of in utero
retention according to Genest’s criteria [21–23]. Graphs present data for
A) Syncytial nuclear aggregates (SNAs) B) Proliferation, C) Trophoblast
area, D) Villous vascularity, E) Proportion of avascular villi and F) Number
of Leukocytes per 1,000 nuclei. Graphs present the median and
interquartile range for each group. There is no statistically significant
difference of the frequency of the morphological feature and the groups
divided by in utero retention. (PPTX 197 kb)
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